Price T Rowe Associates Inc Cerus Corp Transaction History

Price T Rowe Associates Inc

  • $935 Billion
  • Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Cerus Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 93,278 shares of CERS stock, worth $151,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93,278
Previous 273,407 65.88%
Holding current value
$151,110
Previous $386,000 61.4%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$1.16 - $1.6 $208,949 - $288,206
-180,129 Reduced 65.88%
93,278 $149,000
Q2 2025

Aug 14, 2025
BUY
$1.22 - $1.51 $5,175 - $6,405
4,242 Added 1.58%
273,407 $386,000
Q1 2025

May 14, 2025
BUY
$1.39 - $2.15 $48,494 - $75,009
34,888 Added 14.89%
269,165 $375,000
Q4 2024

Feb 14, 2025
BUY
$1.52 - $2.03 $52,734 - $70,428
34,694 Added 17.38%
234,277 $361,000
Q3 2024

Nov 14, 2024
BUY
$1.7 - $2.39 $2,159 - $3,035
1,270 Added 0.64%
199,583 $348,000
Q2 2024

Aug 14, 2024
BUY
$1.62 - $2.04 $8,812 - $11,097
5,440 Added 2.82%
198,313 $350,000
Q1 2024

May 15, 2024
BUY
$1.66 - $2.42 $14,910 - $21,736
8,982 Added 4.88%
192,873 $365,000
Q4 2023

Feb 14, 2024
BUY
$1.25 - $2.35 $68,442 - $128,671
54,754 Added 42.4%
183,891 $398,000
Q3 2023

Nov 14, 2023
BUY
$1.5 - $3.07 $2,637 - $5,397
1,758 Added 1.38%
129,137 $210,000
Q2 2023

Aug 14, 2023
BUY
$1.79 - $2.9 $5,951 - $9,642
3,325 Added 2.68%
127,379 $314,000
Q1 2023

May 15, 2023
SELL
$2.65 - $3.81 $2,756 - $3,962
-1,040 Reduced 0.83%
124,054 $369,000
Q4 2022

Feb 14, 2023
SELL
$3.38 - $4.22 $223,286 - $278,777
-66,061 Reduced 34.56%
125,094 $457,000
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.83 $35,469 - $60,288
10,341 Added 5.72%
191,155 $689,000
Q2 2022

Aug 15, 2022
SELL
$4.41 - $5.69 $194 - $250
-44 Reduced 0.02%
180,814 $957,000
Q1 2022

May 16, 2022
BUY
$4.81 - $6.99 $18,263 - $26,541
3,797 Added 2.14%
180,858 $993,000
Q4 2021

Feb 14, 2022
BUY
$5.97 - $7.93 $406,658 - $540,167
68,117 Added 62.52%
177,061 $1.21 Million
Q3 2021

Nov 15, 2021
BUY
$4.79 - $6.68 $1,719 - $2,398
359 Added 0.33%
108,944 $663,000
Q2 2021

Aug 16, 2021
SELL
$5.35 - $6.35 $44,736 - $53,098
-8,362 Reduced 7.15%
108,585 $642,000
Q1 2021

May 17, 2021
BUY
$5.68 - $7.87 $162,175 - $224,704
28,552 Added 32.3%
116,947 $703,000
Q4 2020

Feb 16, 2021
BUY
$5.25 - $8.56 $464,073 - $756,661
88,395 New
88,395 $612,000

Others Institutions Holding CERS

# of Institutions
167
Shares Held
135M
Call Options Held
126K
Put Options Held
30.1K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $287M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email